Lipid Lowering Effect, and Lipidomic Profiles by Genotype of OATP1B1 and BCRP After Administration of Rosuvastatin in Patients With Hyperlipidemia.
Phase of Trial: Phase IV
Latest Information Update: 15 May 2014
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics; Pharmacogenomic
- 10 Nov 2011 New trial record